Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (25)

2024

  1. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

2022

  1. Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy

    Indian Journal of Ophthalmology, Vol. 70, Núm. 5, pp. 1626-1633

  2. Clinical characteristics of full thickness macular holes that closed without surgery

    British Journal of Ophthalmology, Vol. 106, Núm. 10, pp. 1463-1468

  3. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    The Lancet, Vol. 399, Núm. 10326, pp. 729-740

  4. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

2021

  1. Perimetría en domicilio. ¿Es posible?

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 6, pp. 285-287

  2. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

  3. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

    Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870

2020

  1. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829

  2. Macular ganglion cell complex thinning in children with visual field defects due to central nervous system pathology

    Eye (Basingstoke), Vol. 34, Núm. 9, pp. 1570-1576

2019

  1. The EX-PRESS glaucoma shunt versus nonpenetrating deep sclerectomy with Esnoper implant in combined surgery for open-angle glaucoma: a prospective randomized study

    Acta Ophthalmologica, Vol. 97, Núm. 7, pp. e952-e961

2018

  1. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

    Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212

  2. Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants

    Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72

2017

  1. Prevalence of Vitreoretinal Interface Abnormalities on Spectral-Domain OCT in Healthy Participants over 45 Years of Age

    Ophthalmology Retina

2016

  1. A diagnostic calculator for detecting glaucoma and false positive using cirrus OCT

    Investigative Ophthalmology and Visual Science

  2. Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 14, pp. 6447-6454

2015

  1. Current Approach in the Diagnosis and Management of Uveitic Glaucoma

    BioMed Research International, Vol. 2015

  2. Current state of therapeutic strategies with ranibizumab in neovascular age-related macular degeneration

    Current Opinion in Ophthalmology, Vol. 26, Núm. 3, pp. 200-205

  3. Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

    Journal of Ophthalmology, Vol. 2015

  4. Re: Kim et al.: Diagnostic classification of macular ganglion cell and retinal nerve fiber layer analysis: differentiation of false-positives from glaucoma (Ophthalmology 2015;122:502-10)

    Ophthalmology